CompletedNCT02221336
Official study titleDaily Electronic Monitoring of Subjective and Objective Measures of Illness Activity in Bipolar Disorder - The MONARCA II Trial (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes II)
This study has finished and is no longer accepting participants.
In CopenhagenBipolarityDevice studyAges 18+
- Countries
- Denmark
- Sponsor
- Psychiatric Centre Rigshospitalet
CompletedNCT01476527
Official study titleDeep Brain Stimulation for the Treatment of Refractory Bipolar Disorder: Pilot Trial
This study has finished and is no longer accepting participants.
In TorontoBipolarityInterventional studyAges 30–60
- Countries
- Canada
- Sponsor
- University Health Network, Toronto
CompletedNCT04276883
What is this study about?Researchers compared Sublingual film containing Dexmedetomidine (BXCL501) and placebo to find out how the approaches affected psychotic symptoms in people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockBipolarityMedication studyAges 18–75
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
CompletedNCT01750255
Official study titleEffect of Pharmaceutical Care in Patients With Bipolar I Disorder at St John of God Clinic. Randomized Trial.
This study has finished and is no longer accepting participants.
In La CejaBipolarityPlacebo comparisonAges 18–65
- Countries
- Colombia
- Sponsor
- Universidad de Antioquia
CompletedNCT00159562
Official study titleEffects of Psycho-education of Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In TrondheimBipolarityBehavioural studyAges 18–70
- Countries
- Norway
- Sponsor
- Norwegian University of Science and Technology
UnknownNCT04230421
About this title
Effects of Smartphone-based Treatment for Bipolar Disorder - the Smart Bipolar
Read the official source — NCT04230421Official study titleEffects of Smartphone-based Treatment for Bipolar Disorder - the Smart Bipolar RCT
Current recruitment status is unconfirmed.
In CopenhagenBipolarityDevice studyAges 18+
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
TerminatedNCT01467713
Official study titleA Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar I Disorder in Adult Patients
This study ended early.
Multiple locations, including BirminghamBipolarityMedication studyAges 18–75
- Countries
- United States, Argentina, Chile, + 2 others
- Sponsor
- Takeda
CompletedNCT06782763
Official study titleA Randomized Controlled Study on the Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In HangzhouBipolarityDevice studyAges 14–45
- Countries
- China
- Sponsor
- First Affiliated Hospital of Zhejiang University